Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis

BACKGROUND:  New first-line drug regimens for treatment of tuberculosis (TB) are in clinical trials: emergence of resistance is a key concern. Because population-level data on resistance cannot be collected in advance, epidemiological models are important tools for understanding the drivers and dyna...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Sourya, Knight, Gwenan M., Fofana, Mariam, Cohen, Ted, White, Richard G., Cobelens, Frank, Dowdy, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281792/
https://www.ncbi.nlm.nih.gov/pubmed/25734143
http://dx.doi.org/10.1093/ofid/ofu073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281792/
https://www.ncbi.nlm.nih.gov/pubmed/25734143
http://dx.doi.org/10.1093/ofid/ofu073

Ejemplares similares